ANALYSIS OF BASELINE CHARACTERISTICS ASSOCIATED WITH CLINICAL RESPONSE TO USTEKINUMAB IV RE-INDUCTION STRATEGY IN PATIENTS WITH CROHN’S DISEASE IN THE POWER TRIAL

Ignacio Marín-Jiménez  1     Stefan Schreiber  2     Scott Lee  3     C. Janneke van der Woude  4     Doug Wolf  5     Elisabeth Schnoy  6     Bruce Salzberg  7     Christopher Busse  8     Maciek Nazar  9     Wayne Langholff  10     Chris Gasink  8     Thomas Baker  10     Bridget Godwin  8     Brian G. Feagan  11    
1 Hospital Universitario Gregorio Marañón, IiSGM, Madrid, Spain
2 Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany
3 University of Washington, Seattle, United States
4 Erasmus University Medical Center, Rotterdam, Netherlands
5 Atlanta Gastroenterology Associates, Atlanta, United States
6 University Hospital of Augsburg, Augsburg, Germany
7 IBD Center of Atlanta, Atlanta, United States
8 Janssen Scientific Affairs, LLC, Horsham, United States
9 Janssen-Cilag Polska Sp. z o.o., Warsaw, Poland
10 Janssen Research & Development, LLC, Spring House, United States
11 University of Western Ontario, London, Canada

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing